Literature DB >> 18031366

Characteristics of acute and sub-acute liver failure in China: nomination, classification and interval.

Qing Liu1, Zheng Liu, Tailing Wang, Qingguo Wang, Xiaohong Shi, Wenbin Dao.   

Abstract

BACKGROUND AND AIMS: Unlike most other countries, in China, liver failure is termed as severe hepatitis. However, there are two differences between liver failure and severe hepatitis: the interval of acute and sub-acute severe hepatitis and the etiology. The aims of this study were to assess the best cutoff time-point to distinguish between acute and sub-acute severe hepatitis caused mainly by hepatitis B virus (HBV; 67.5%) in China and to determine whether the Chinese classifications of severe hepatitis can meet the international criteria based on pathological features and clinical characteristics.
METHODS: A total of 157 patients with acute, sub-acute and chronic severe hepatitis were involved in the study. Their clinical findings, laboratory data and liver biopsies were retrospectively analyzed.
RESULTS: The different incidences of complications between acute and sub-acute severe hepatitis were significant if the cutoff point was set at 15 days or 4 weeks (P < 0.01), but there is no significant differences if the cutoff was 8 weeks. Identifying the better cutoff point with a receiver-operator characteristic curve showed that 28 days was better than 15 days (sensitivity 100%vs 92%; specificity 75%vs 53%). The major differences in histopathology between acute and sub-acute severe hepatitis were: (i) there was a single hepatic necrosis in acute severe hepatitis, but repeated and continuous hepatic necrosis in sub-acute severe hepatitis; and (ii) survivors of acute severe hepatitis had full hepatocyte regeneration in the native liver architecture. Regeneration in survivors with sub-acute severe hepatitis indicated the destruction of nodular architecture; new and old necrosis appeared at the same time. When the cutoff point for acute and sub-acute severe hepatitis was set at 15 days, some sub-acute severe hepatitis cases (full hepatocyte regeneration and one massive necrosis) had an overlap in pathological features with acute severe hepatitis. If the cutoff time-point was set at 4 weeks, the clinical features between acute and sub-acute, as well as the pathological changes, were clearly distinguished.
CONCLUSION: The best cutoff time-point to distinguish between acute and sub-acute severe hepatitis is 4 weeks. This classification meets the international criteria based on the present clinical and pathological results.

Entities:  

Mesh:

Year:  2007        PMID: 18031366     DOI: 10.1111/j.1440-1746.2006.04362.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  30 in total

1.  Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL).

Authors:  Shiv Kumar Sarin; Ashish Kumar; John A Almeida; Yogesh Kumar Chawla; Sheung Tat Fan; Hitendra Garg; H Janaka de Silva; Saeed Sadiq Hamid; Rajiv Jalan; Piyawat Komolmit; George K Lau; Qing Liu; Kaushal Madan; Rosmawati Mohamed; Qin Ning; Salimur Rahman; Archana Rastogi; Stephen M Riordan; Puja Sakhuja; Didier Samuel; Samir Shah; Barjesh Chander Sharma; Praveen Sharma; Yasuhiro Takikawa; Babu Ram Thapa; Chun-Tao Wai; Man-Fung Yuen
Journal:  Hepatol Int       Date:  2008-11-20       Impact factor: 6.047

2.  Liver histology as predictor of outcome in patients with acute-on-chronic liver failure (ACLF).

Authors:  Archana Rastogi; Ashish Kumar; Puja Sakhuja; Chhagan Bihari; Ranjana Gondal; Syed Hissar; Hitendra Garg; Shiv Kumar Sarin
Journal:  Virchows Arch       Date:  2011-07-09       Impact factor: 4.064

Review 3.  Genetic variation of hepatitis B virus and its significance for pathogenesis.

Authors:  Zhen-Hua Zhang; Chun-Chen Wu; Xin-Wen Chen; Xu Li; Jun Li; Meng-Ji Lu
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

4.  Short-term efficacy of treating hepatitis B virus-related acute-on-chronic liver failure based on cold pattern differentiation with hot herbs: A randomized controlled trial.

Authors:  Yu-Ming Guo; Feng-Yi Li; Man Gong; Lin Zhang; Jia-Bo Wang; Xiao-He Xiao; Jun Li; Yan-Ling Zhao; Li-Fu Wang; Xiao-Feng Zhang
Journal:  Chin J Integr Med       Date:  2016-05-24       Impact factor: 1.978

5.  Invasive pulmonary aspergillosis in patients with HBV-related liver failure.

Authors:  W Wang; C Y Zhao; J Y Zhou; Y D Wang; C Shen; D F Zhou; H Z Yin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-01-04       Impact factor: 3.267

6.  Intrahepatic expression of programmed death-1 and its ligands in patients with HBV-related acute-on-chronic liver failure.

Authors:  Dayan Cao; Huan Xu; Guoning Guo; Zhihua Ruan; Lei Fei; Zhunyi Xie; Yuzhang Wu; Yongwen Chen
Journal:  Inflammation       Date:  2013-02       Impact factor: 4.092

Review 7.  Acute and acute severe (fulminant) autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2012-10-23       Impact factor: 3.199

8.  Portalsystemic hemodynamic changes in chronic severe hepatitis B: An ultrasonographic study.

Authors:  Zhong-Zhen Su; Hong Shan; Wei-Min Ke; Bing-Jun He; Rong-Qin Zheng
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

9.  Sorafenib-induced acute-on-chronic liver failure in a patient with hepatocellular carcinoma after transarterial chemoembolization and radiofrequency ablation: A case report.

Authors:  Qing-Liang Wang; Xiao-Jie Li; Zhi-Cheng Yao; Peng Zhang; Shi-Lei Xu; He Huang; Kun-Peng Hu
Journal:  Mol Clin Oncol       Date:  2017-08-03

10.  Hepatitis B virus genotype and basal core promoter/precore mutations are associated with hepatitis B-related acute-on-chronic liver failure without pre-existing liver cirrhosis.

Authors:  X Ren; Z Xu; Y Liu; X Li; S Bai; N Ding; Y Zhong; L Wang; P Mao; F Zoulim; D Xu
Journal:  J Viral Hepat       Date:  2010-12       Impact factor: 3.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.